Dr Patrick Coloby graduated in General Surgery and in Urology in 1982 from the University Pierre et Marie Curie Paris VI. He became a foreign research Fellow of the foundation for promotion of cancer research at Tokyo cancer center hospital in 1990-1991, and a Fellow of the European Board of Urology (FEBU) in 1992. He was qualified in Onco Urology in 1992. He has been Chairman of the Department of Urology at René Dubos Hospital in Pontoise since 1984. He was an active member of the French Urological Association (AFU) as its General secretary (1998-2004 and 2007-2010) and as its President (2010-2013). He is a member of several international scientific organizations as a consultant of the International Relation Office of European Association of Urology (EAU), as the Treasurer of the Société Internationale d’Urologie (SIU) (2006-2011), and as the President of SIU since 2015. He developed the concept and the surgical technique of neobladder in female patients after cystectomy. He has published as first author or coauthor over 120 papers.
Patrick Coloby will present the SIU Lecture
Dr Stephen A. Boorjian is the Carl Rosen Professor of Urology, Vice Chair of Research in Urology, and the Director of the Urologic Oncology Fellowship at Mayo Clinic. He received his MD from Harvard Medical School, and was a resident in Urology at New York Presbyterian Hospital-Weill Cornell Medical Center. He subsequently completed a fellowship in Urologic Oncology at Mayo Clinic. Dr Boorjian has co-authored over 250 manuscripts, and was recognized with the 2014 Young Urologist of the Year award from the AUA and the 2016 SUO Young Investigator award. He currently serves as an Associate Editor for European Urology.
Steven B. Brandes, M.D. is Professor of Urology at Columbia University Medical Center and Chief of Reconstructive Urologic Surgery. Dr Brandes, a renowned expert and thought leader in urologic reconstructive surgery and trauma, and leads the Center for Reconstructive Surgery. He directs a comprehensive and collaborative program along with Gynecology Oncology, Colorectal Surgery and Plastic Surgery to care for patients who require lower urinary tract and genital reconstruction. Additionally, Dr Brandes, in collaboration with pediatric urologists, conducts a cutting edge, adult transition program, for the care of those who were born with congenital urologic abnormalities. Dr Brandes’ research interests are in improving techniques in reconstructive surgery of the genitals and lower urinary tract, urethral stricture surgery, urinary fistula repairs, radiation fistulas, and traumatic urologic injuries. His wet lab research interests are in tissue engineering and regenerative medicine of the urethra, bladder and ureter. Dr Brandes is active as a member many national and international surgical societies. He is currently President–elect of the Society of Genitourinary Reconstructive Surgeons, an august international society.
Professor Christopher Chapple is a Consultant Urological Surgeon at Sheffield Teaching Hospitals and Visiting Professor at Sheffield Hallam University. He has a particular interest in functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms and provides a tertiary service in lower urinary tract reconstructive surgery. He is Secretary General, and Chairman of the International Relations Committee at the European Association of Urology. He is editor-in-chief of the journal Neurourology and Urodynamics and is on the editorial board of several journals such as the British Journal of Urology, European Urology, Surgery and Current Opinion in Urology. He is an active member of many international urological associations and societies including the British Association of Urological Surgeons, the European Association of Urology, the International Continence Society, the Association of Academic European Urologists and the American Association of Genitourinary Surgeons. He has chaired a number of guidelines initiatives including the NICE Guidelines Development Group on male lower urinary tract symptoms. He was awarded the St Peter’s medal by the British Association of Urological Surgeons in 2011.
Dr Chiu is the Secretary General of the Urological Association of Asia, having previously served as President of the Association from 2010 to 2012. He was deputy mayor of Taipei city government from 2007 to 2011, and chief consultant of Taipei city government from 2011 to 2014. Dr Chiu is the recipient of many awards and honours and serves on a number of editorial boards. He has organised more than 30 laparoscopic workshops and training programs in Taiwan, Mainland China, Singapore, and Hong-Kong and performed 35 live surgical demonstrations including 27 international cases. Dr Chiu has published 168 articles in international medical journals, more than 550 presentations and 197 invited speeches in worldwide medical conferences, and is the author of 5 books and chapters. He was President of 32nd World Endourology Congress held from 3 to 7 September 2014, in Taipei.
Prokar Dasgupta has been a Senior Academic Urologist for the past 7 years within the Division of Immunology, Infection and Inflammatory Diseases (DIIID), Guy’s Hospital, King’s College London School of Medicine. Senior faculty member within the GKT Biomedical Research Centre to promote translational research. He has also worked for 10 years in the 5* rated Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square.
He pioneered modern robotic urological surgery in UK, following in the footsteps of John Wickham. His team is recognised internationally for the Guy’s robotic cystoprostatectomy technique for bladder cancer and is the leading European group amongst the International Robotic Cystectomy Consortium (IRCC). He conducted the first randomised controlled trial of robotic urology in collaboration with Johns Hopkins Hospital. A further innovation is the description of a minimally invasive method of delivering Botulinum toxin to refractory overactive bladders (Dasgupta technique). He is the Urological Foundation Mentor in Robotic Surgery. He was elected BAUS councillor and Royal College of Surgeons Specialist Advisor in 2008. He is a Visiting Professor to a number of overseas institutions.
He has over 400 publications which include nearly 170 peer-reviewed papers, 17 chapters and 4 books. He is credited with over 250 presentations in national and international meetings. He has raised almost £3 million through 34 grants including those from the MRC, MS Society and BUF. He has established numerous collaborations in basic science research the most recognised of these being the understanding of receptor function in the human and rat bladders and the translational implications. He is interested in stem cells in prostate cancer and bladder regeneration and the development of image guidance and indentation probes to improve the accuracy of robotic surgery in urological oncology.
Dr Davis is an Associate Professor of Urology at the University of Texas M.D. Anderson Cancer Center, Houston Texas, where he holds Director titles of the Urosurgical Prostate Cancer Program and Urologic Oncology clinics. His clinical interests are in patients with urologic cancers, laparoscopic/robotic surgery, and general urology. Academic interests include quality of life after prostate cancer treatment, outcomes for robotic radical prostatectomy, high risk prostate cancer trials, active surveillance for prostate cancer, and development of robotic surgical techniques for invasive bladder cancer. He has participated as an investigator in several Southwest Oncology Group and industry sponsored clinical trials. Dr Davis is board certified by the American Board of Urology and is a member of professional organizations including the Society of Urologic Oncology, Endourology Society, Society of Robotic Surgeons, Société Internationale d’Urologie, American Urological Association, and a Fellow of the American College of Surgeons. His leadership positions in professional societies have included President of the Young Urologic Oncologists (2003-2005), and President of the Society of Urologic Robotic Surgeons (2010-2012). For the American Urological Association, he sits on the Bylaws, History, and Minimally Invasive Surgery Committees, teaches a post-graduate course on robotic prostatectomy technique, and is a member of the 2014 Leadership Training Class. He is the Historian for the South Central Section of the AUA, and recently appointed Online Content Editor for the AUA. His peer reviewed publication involvement is highlighted by the role of Associate Editor for Urologic Oncology for the British Journal of Urology International.
James A. Eastham, MD, is Professor and Chief of the Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center in New York. Dr Eastham received his medical degree from the University of Southern California, Los Angeles. He completed an internship in general surgery and a residency in urology at Los Angeles County – University of Southern California Medical Center. He went on to complete a fellowship in urologic oncology at Baylor College of Medicine in Houston, Texas. Prior to his appointment at Memorial Sloan-Kettering Cancer Center, Dr Eastham was an assistant and associate professor in the Department of Urology at Louisiana State University in Shreveport and Chief of Urology at Overton-Brooks Veterans Administration Medical Center in Louisiana.
Dr Eastham’s research has focused on the prevention and treatment of prostate cancer, with a particular interest in improving oncologic and quality-of-life outcomes after radical prostatectomy. He has authored or co-authored over 200 articles which have appeared in peer-reviewed journals such as theJournal of the American Medical Association, Journal of Urology, theJournal of Clinical Oncology,Urology, andTransplantation. In addition, he has authored numerous book chapters, reviews, monographs, and abstracts. He is a fellow of the American College of Surgeons and a member of several professional societies including the American Urologic Association, the Society of Urologic Oncology, and Societé Internationale D’Urologie.
Dr Hansel received her MD and PhD degrees at the Johns Hopkins School of Medicine, where she subsequently completed residency and genitourinary pathology fellowship in the Department of Pathology. Dr Hansel was Assistant and Associate Professor at the Cleveland Clinic from 2006-2013, where she developed her clinical and translational program in bladder cancer research. She was recruited to the University of California at San Diego in 2013 as Full Professor and Chief of the Division of Anatomic Pathology. Dr Hansel is active in laboratory research, clinical sign-out and teaching locally and nationally. Dr Hansel has authored over 100 peer-reviewed publications, edited or authored 5 textbooks on urologic pathology and biospecimen repositories, and has given more than 70 national or international talks on genitourinary pathology. She has participated in the Kidney-Urinary tract panel for the upcoming 8th Edition of the AJCC Cancer Staging Manual and contributed to the newly released 4th edition of the WHO Classification of Tumours of the Urinary System and Male Genital Organs. She is currently on the Editorial Board for Advances in Anatomic Pathology and is a section editor for urologic oncology in Archives of Pathology and Laboratory Medicine and has mentored over 20 residents, graduate students and postdoctoral fellows. Dr Hansel is a member of Alpha Omega Alpha and has recently been awarded the Ramzi S. Cotran Young Investigator Award by the United States and Canadian Academy of Pathology.
Dr Nitin Kekre is Professor and Head of Urology and Renal Transplantation Unit II at the Christian Medical College, Vellore, India. Dr Kekre worked as a Senior Registrar at Freeman Hospital, New Castle Upon Tyne and as a Consultant Urologist at Sunderland Royal Hospital. He is a past Editor-In-Chief, and currently the Chairman of the Board of the Indian Journal of Urology. Dr Kekre has served on the Executive Board of the British Journal of Urology and the Editorial Board of the International Journal of Urology. His academic interests are uro-oncology and neuro-urology. In 2013 the Urological Society of India conferred the President’s Gold Medal on Dr Kekre.
Laurence Klotz, M.D. is the past Chief of Urology at Sunnybrook Health Sciences Centre and Professor of Surgery at the University of Toronto. He is Chairman of the World Uro-Oncology Federation and a past president of the Urological Research Society and the Canadian Urological Association. Dr Klotz was the Founding Editor-in-Chief of both the Canadian Journal of Urology and the Canadian Urology Association Journal, and is now Editor Emeritus of the CUAJ. He was the founder and is chairman of the Canadian Urology Research Consortium (CURC). Dr Klotz obtained his medical degree from the University of Toronto and completed his residency at the University of Toronto Gallie Program in Surgery. He was a fellow at Memorial Sloan Kettering Cancer Centre in New York in uro-oncology. Dr Klotz is a widely published uro-oncologist with over 350 publications and 5 books. His main research interest has been prostate cancer. Dr Klotz has led many research studies in prostate cancer, including basic research studies of the role of micronutrients and diet in prostate cancer prevention, translational research, and clinical studies in every facet of prostate cancer. His major clinical research interests have been in the areas of active surveillance for low risk prostate cancer, intermittent androgen deprivation and other aspects of androgen deprivation, and MRI guided ultrasound ablation.
Laurence A. Levine, MD is Professor in the Department of Urology at Rush University Medical Center in Chicago, Illinois. Dr Levine received his MD from the University of Colorado Medical School in Denver, followed by a residency in urology at Brigham and Women’s Hospital–Harvard Medical School in Boston, Massachusetts. He is board certified in urology.
Dr Levine’s research interests include multiple areas of men’s health, including Peyronie’s disease, erectile dysfunction, male hypogonadism, urethral strictures, and chronic genital pain.
Dr Levine has authored or coauthored book chapters, abstracts, and more than 160 articles published in peer-reviewed journals, including The Journal of Urology, The Journal of Sexual Medicine, and Asian Journal of Andrology. He has authored 2 books on Peyronie’s disease entitled Peyronie’s Disease: A Guide to Clinical Management (Humana Press) and Understanding Peyronie’s Disease: A Treatment Guide for Curvature of the Penis (Addicus Books, Inc.). He serves on the editorial advisory board of The Journal of Sexual Medicine and is a reviewer for several journals, including the British Journal of Urology International, The Journal of Urology, and The Journal of Sexual Medicine.
He is a fellow of the American College of Surgeons and past President of the Sexual Medicine Society of North America and the Chicago Urological Society. He is a member of the Sexual Medicine Society of North America, American Association of Clinical Urologists, American Urological Association, Society of Genitourinary Reconstructive Surgeons, and International Society for Sexual and Impotence Research. He received a Lifetime Achievement Award from the Sexual Medicine Society of North America in 2015 and has been listed as a Top Doctor in Chicago for the past 16 years.
Ass. Professor Paediatric Surgery & Paediatric Urology, U. de Chile
President Chilean Society Paediatric Surgery (SChCP)
Past President Iberoamerican Society Paediatric Urology (SIUP)
Staff Paediatric Urologist
Hospital Exequiel Gonzalez Cortes & Clinica Alemana, Santiago, Chile
Dr P.J. Lopez has a specific interest in complex reconstructive urological pathology, and minimal invasive surgery as a way of further development. He is also involved in facilitating the smooth transition from paediatric to adult practice by enhancing adolescent management. One of his career aims is to be at forefront of this development in establishing the scientific basis and translating this into first class clinical service. That is why he in on editorial boards of 5 journals, has published over 45 chapters; has edited 1 book, 2 academic website and has published over 120 papers. He is also a recognized international speaker. He is an active member of more than 10 scientific societies and is currently on the board of four of these; including President of the Chilean Society of Paediatric Surgery.
Southern Illinois University School of Medicine, USA
Kevin T. McVary, M.D., is Professor of Urology at Southern Illinois University School of Medicine in Springfield, Illinois. He specializes in male urology problems including prostate cancer and prostatic disorders as well as BPH (enlarged prostate), and the evaluation and treatment of sexual function and erectile dysfunction.
Dr. McVary received his medical degree at Northwestern University Medical School. He completed his postdoctoral training at Northwestern Memorial Hospital, including an internship and residency in general surgery as well as a residency in urology and was Chief Resident in urology at the hospital. In addition, he was granted a Riba Urology Research Fellowship under the direction of Chung Lee, Ph.D. at Northwestern.
An experienced investigator in prostatic disorders and erectile dysfunction (ED), Dr. McVary is currently and has recently been principal investigator for more than 115 clinical trials, many of which re through the National Institute of Health. His research has generated more than 350 publications, including refereed journal articles, books, book chapters and abstracts. His work has appeared in prominent journals such as the Journal of Urology, New England Journal of Medicine, International Journal of Impotence Research, and Urology. Among his editorial responsibilities are consultant for the Journal of Andrology, Journal of Urology, Urology, Journal of Investigative Urology, Current Opinion in Urology, Prostate Diseases, and book reviewer for the Journal of Urology.
A Fellow of the American College of Surgeons and Diplomat of the American Urological Association, Dr. McVary is also an active member of many other organizations such as the American Association of Genitourinary Surgeons, Sexual Medicine Society of North America, and others..
Professor, Department of Urology, Queen’s University
Canada Research Chair in Urologic Pain and Inflammation
President of the Canadian Urological Association
Staff Urologist, Department of Urology, Kingston and Hotel Dieu General Hospitals
Kingston, Ontario, Canada
Dr Nickel’s research covers inflammatory (including infections), benign prostate (BPH) and pain diseases (prostatitis and interstitial cystitis) of the urinary tract. He has over 500 publications, is on the editorial board of 8 Urology journals, presented in 45 countries, funded by US NIH and Canadian CIHR and was awarded a CIHR Tier I Canada Research Chair (concurrent), AUA Distinguished Contribution Award and SIU Academy Award. He is currently President of the Canadian Urological Association.
Victor W. Nitti, MD, is Professor of Urology and Obstetrics and Gynecology and the Vice Chairman of the Department of Urology at New York University Langone Medical Center. He is also the head of Female Pelvic Medicine and Reconstructive Surgery and is the fellowship director for that ACGME accredited program. Dr Nitti is an authority in urodynamic techniques, medical and surgical therapies for urinary incontinence, pelvic organ prolapse, female pelvic reconstructive surgery and voiding dysfunction. He has authored over 130 peer-reviewed articles as well and over 60 book chapters on these subjects. He is the editor of two text books: Practical Urodynamics, published by W.B. Saunders and Vaginal Surgery for the Urologist published by Elsevier. He has presented his research at national and international meetings and has been invited as a visiting professor and participated in postgraduate courses throughout the world. Dr Nitti currently holds the position of Chair, American Urological Association Office of Education; and serves on the FPMRS Division of the American Board of Obstetrics and Gynecology and on the Board of Directors for the New York Section of the AUA. Dr Nitti is on the editorial boards of Neurourology and Urodynamics, the Journal of Female Pelvic Medicine and Reconstructive Surgery, and the International Urogynecology Journal.
Mr Kieran O’Flynn graduated in Medicine from the University College, Dublin. He trained in the Republic of Ireland, Scotland and Sheffield before settling in Manchester. He has been a consultant Urological Surgeon at Salford Royal since 1994 and became President of BAUS in 2016. His main interests are in the area of BPH, functional urology and continence management. He has previously acted as Regional Advisor in Urology for the North West and is the Director of Education for the British Association of Urological Surgeons. He currently chairs the Specialist Advisory committee in Urology which oversees training in Urology in the UK and Ireland.
Maria J. Ribal received her medical degree in 1994, followed by her PhD in 2002, both at the University of Barcelona. She attended as Visiting Clinician at Mayo Clinic in Rochester (USA) in 2002. She was Fellow in Laparoscopic Surgery at the University College London Hospital (UCLH) from June till December 2006. From 2002 to 2005 she was a member of the Oncology Unit of the Department of Urology at Fundacio Puigvert. Since February 2005, she has been a member of the Department of Urology at the University Hospital Clinic of Barcelona, and currently she is Associate Professor of Surgery at the University of Barcelona. From December 2011 she has been the Head of the Multidisciplinary Unit of Uro-Oncology at Hospital Clinic. She is the author of 70 international and national publications, 10 book chapters, and >200 invited lectures at conferences and courses. Maria is an active member of the European Association of Urology, and has been a member of the Muscle Invasive and Metastatic Bladder Cancer Guidelines Group of the European Association of Urology (EAU) since 2006; and a member of the ESUT Working group from EAU since 2010. She has been a Board member of the EUSP Office of the EAU since April 2012 and a Board Member of the EAU Guidelines Office since January 2016. In 2009, during the EAU Annual Meeting held in Stockholm, she received the Crystal Matula award.
Dr Olivier Traxer is Professor of Urology: University of Paris 6th (Pierre et Marie Curie) and works in Tenon Hospital. He did a research-fellowship at Southwestern Medical School, University of Texas, Dallas-USA (Charles Y.C PAK & Margaret Sue PEARLE) to subspecialize in Endourology and kidney stone management. As an endo-urologist, his main goal is to improve the knowledge on urinary stone disease and endourology. Dr Traxer is responsible in Tenon Hospital (University Pierre et Marie Curie Paris-6) of the minimaly invasive surgery section and published more than 210 peer-reviewed papers. Dr Traxer is a board member of the EndoUrological Society, the French Association of Urology (AFU) and EAU board member of the EULIS, ESUT and ESU office. He is also the treasurer of SIU. He received in 2010 (Chicago-WCE) the Arthur Smith Award.